slides · global inventory
Quote
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 18,554
Current window 7,081-7,110
Pages 619
Rows per page 30
Component
7,081-7,110 of 18,554
04
The slide uses a direct quote to frame the company's sales practices as unethical or problematic.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · Setup & Stakes2 hits
05
The slide uses a testimonial to cast doubt on the company's reported metrics.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · Setup & Stakes2 hits
38
The slide uses a combination of summary text and a direct testimonial quote to establish a pattern of behavior.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Struggle2 hits
40
The slide uses a testimonial quote to support a narrative of corporate malfeasance and trial data manipulation.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Struggle2 hits
51
The slide uses a quote from a 2004 NEJM paper to establish a precedent of drug withdrawal, then links the molecular structure (piperidine ring) and receptor activity of pitolisant to these withdrawn drugs.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The VictoryLoop · The Reveal2 hits
82
The slide uses a 'villain critique' style to undermine the target drug (pitolisant) by associating it with failed industry-wide efforts.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 2 hits
96
The slide uses a Q&A format to discredit the competitor's R&D rigor.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 2 hits
105
The slide uses a 'quote-and-critique' structure to expose potential data manipulation in clinical reporting.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 2 hits
120
The slide uses a combination of narrative argument and a direct quote from a consultant to build a case against the company's transparency.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 2 hits
121
The slide presents a direct quote from a PK expert to undermine the validity of the company's safety assertions.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 2 hits
130
The slide uses direct citations from FDA and research documents to highlight the discrepancy between single-dose study designs and the need for steady-state peak plasma concentration analysis.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 2 hits
131
The slide uses a quote from a pharmacology consultant to argue that safety margins are overestimated due to drug accumulation.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 2 hits
140
The slide uses a quote from a consultant to challenge the validity of the company's (Harmony) data submitted to the FDA.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 2 hits
158
The slide uses direct quotes from FDA clinical reviews to highlight the discrepancy between pre-approval assumptions and post-approval safety signals.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 2 hits
204
The slide highlights a discrepancy between the drug's safety profile as presented and the real-world experience of a physician.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 2 hits
226
The slide uses a direct quote from a Lancet letter to undermine the credibility of the HARMONY 1 trial investigators.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 2 hits
257
Includes highlighted text emphasizing the shift in sentiment from bullish to skeptical.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 2 hits
277
The slide uses a Q&A format to validate the prescriber's credentials and patient volume.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 2 hits
286
The slide highlights a potential safety concern and a perceived lack of transparency or concern from the manufacturer's sales representative.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 2 hits
309
The slide uses a combination of summary points and direct excerpts from a pharmacology consultant's review to build a case of scientific negligence or misrepresentation.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 2 hits
312
The slide uses a combination of summary text, a screenshot of the original study abstract, and a pull-quote from an expert review to discredit the study's findings.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 2 hits
313
Includes a quote from a pharmacology consultant comparing pitolisant to antihistamines.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 2 hits
323
The slide uses highlighted text to emphasize key admissions of fraud/inducement.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 2 hits
330
Includes a Q&A transcript excerpt highlighting the 'buddy' system used to submit fake referrals.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 2 hits
122
The slide uses a direct quote from an internal paper to contradict the company's public narrative on scalability.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 2 hits
128
The slide uses a direct expert quote to undermine the company's technical viability.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 2 hits
155
The slide uses a combination of narrative accusation and direct quotes from earnings materials to build a case of financial misrepresentation.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 2 hits
165
Uses a red arrow to connect the visual marketing material to the CEO's specific claims.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 2 hits
172
The slide uses a 'villain' framing by questioning the capacity of the subject to fulfill all stated obligations.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 2 hits
176
The slide uses a highlight to emphasize the core contradiction in the quote.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 2 hits